B. S. Abdulkarim
Associate Professor
DEPARTMENT OF PATHOLOGY
McGill University
Canada
Biography
Dr. Bassam Abdulkarim is an Associate Professor in the Department of Oncology (Director, Division of Radiation Oncology, since April, 2011) and principle investigator at the Research Institute of the MUHC. Dr. Abdulkarim joined the Department of Pathology as an associate member in 2013.
Research Interest
Dr. Abdulkarim’s main research focus is on translational research in Lung cancer and Brain tumor. His is currently investigating the effect of different types of radiation fractionation including ablative dose of radiation in lung cancer and brain tumor. Dr. Abdulkarim’s major interest is to develop prognostic and predictive biomarkers to radiation alone or in combination with new-targeted therapies. In addition, one of his research interests is focusing on the “comprehensive approach of lung cancer, radiation-induced fibrosis, and development of new therapeutics.
Publications
-
A Phase I Study of Tomotherapy in Patients With Primary Benign and Low-grade Brain Tumors: Late Toxicity and Quality of Life. Boychak A, Bauman G, Fisher B, Abdulkarim B, Amanie J, Fulton D, Murtha A, Patel S, Urtasun R, Ghosh S, Roa WH. Am J Clin Oncol. 2014 Jan 22.
-
Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays. Jung K, Wang P, Gupta N, Gopal K, Wu F, Ye X, Alshareef A, Bigras G, McMullen TP, Abdulkarim BS, Lai R. Breast Cancer Res. 2014 Nov 8;16(6):470.
-
YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells. Jung K, Wu F, Wang P, Ye X, Abdulkarim BS, Lai R. BMC Cancer. 2014 May 9;14:328.
